ASCLF fundamentals
An in-depth look to Ascletis Pharma Inc. operating, investing, and financing activities
ASCLF free cash flow for H2 23 is -11.25 M USD. For 2023, ASCLF free cash flow was -21.27 M USD and operating cash flow was -20.4 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM